The global Blood Group Typing Market was valued at USD 1.67 billion in 2016 and is projected to reach USD 3.76 billion by 2025, growing at a CAGR of 9.44% from 2017 to 2025.
Blood Typing is a very important part of medical procedures involving prenatal diagnostics, Transfusions and transplantations. The rising number of these processes in the healthcare field is the reason causing blood typing to grow.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing blood donation activities
1.2 Growing incidences of trauma, accidents and surgeries requiring blood transfusion
1.3 Growing demand of blood typing in prenatal testing
1.4 Growing importance of forensic studies and blood typing requirement in the forensic studies and examinations
1.5 Stringency towards careful blood transfusions
2. Market Restraints
2.1 High cost of equipment making it less accessible in developing nations
Market Segmentation:
1. Global Blood Group Typing Market, by Technique:
1.1 PCR-Based and Microarray Techniques
1.2 Assay-Based Techniques
1.3 Massively Parallel Sequencing
1.4 Other Techniques
2. Global Blood Group Typing Market, by Products and Services:
2.1 Consumables
2.1.1 Antisera Reagents
2.1.2 Red Blood Cell Reagents
2.1.3 Anti-Human Globulin Reagents
2.1.4 Blood Bank Saline
2.2 Instruments
2.3 Services
3. Global Blood Group Typing Market, by End User:
3.1 Hospitals
3.2 Clinical Laboratories
3.3 Blood Banks
3.4 Other End Users
4. Global Blood Group Typing Market, by Test Type:
4.1 Antibody Screening
4.2 HLA Typing
4.3 ABO Blood Tests
4.4 Cross-Matching Tests
4.5 Antigen Typing
5. Global Blood Group Typing Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Bio-Rad Laboratories, Inc.
2. Beckman Coulter (A Subsidiary of Danaher)
3. Grifols International, S.A.
4. Immucor, Inc.
5. Merck KGaA
6. Novacyt Group
7. Quotient, Ltd.
8. Ortho Clinical Diagnostics, Inc.
9. Bag Health Care GmbH
10. Rapid Labs
11. AXO Science
12. Agena Bioscience, Inc.
13. Day Medical SA
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Blood Group Typing Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BLOOD GROUP TYPING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BLOOD GROUP TYPING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BLOOD GROUP TYPING MARKET, BY TECHNIQUE
5.1 PCR-Based and Microarray Techniques
5.2 Assay-Based Techniques
5.3 Massively Parallel Sequencing
5.4 Other Techniques
6 GLOBAL BLOOD GROUP TYPING MARKET, BY PRODUCTS AND SERVICES
6.1 Consumables
6.1.1 Antisera Reagents
6.1.2 Red Blood Cell Reagents
6.1.3 Anti-Human Globulin Reagents
6.1.4 Blood Bank Saline
6.2 Instruments
6.3 Services
7 GLOBAL BLOOD GROUP TYPING MARKET, BY END USER
7.1 Hospitals
7.2 Clinical Laboratories
7.3 Blood Banks
7.4 Other End Users
8 GLOBAL BLOOD GROUP TYPING MARKET, BY TEST TYPE
8.1 Antibody Screening
8.2 HLA Typing
8.3 ABO Blood Tests
8.4 Cross-Matching Tests
8.5 Antigen Typing
9 GLOBAL BLOOD GROUP TYPING MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL BLOOD GROUP TYPING MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Bio-Rad Laboratories, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Beckman Coulter
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Grifols International, S.A.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Immucor, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Merck KGaA
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Novacyt Group
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Quotient, Ltd.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Ortho Clinical Diagnostics, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Bag Health Care GmbH
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Rapid Labs
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 AXO Science
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Agena Bioscience, Inc.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
11.13 Day Medical SA
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments
12 Appendix
12.1 Related Reports
The Blood Relationship Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Group Benefits Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Blood Bank Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Market Overview
The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...
Market Overview
The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...
Market Overview
The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...
Market Overview
The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...
Market Overview
The North America Ambulance Equipment Market is expected to witness robust growth from 2024 to 2034, driven by the increasing incidence of medical emergencies, advancements in medical technologies, and the expanding healthcare infrastructure. By 2034, the market is proje...